A Study of LY2835219 in Participants With Cancer

NCT02117648 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm
Neoplasm Metastasis

Interventions

DRUG: Abemaciclib
DRUG: Clarithromycin

Sponsor

Eli Lilly and Company